- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
Boston Scientific sees sales increases in 1999
Interventional medical device manufacturer Boston Scientific reported healthy results for fourth quarter and fiscal 1999 (end-December). The Natick, MA, company posted net sales for the quarter of $717 million, flat with sales for the same period in
Interventional medical device manufacturer Boston Scientific reported healthy results for fourth quarter and fiscal 1999 (end-December). The Natick, MA, company posted net sales for the quarter of $717 million, flat with sales for the same period in 1998. Net income was $107 million, up from $71 million the previous year. For the year, the company saw a 27% increase in net sales, from $2.2 billion in 1998 to $2.8 billion in 1999. Net income for the year was $371 million. Excluding charges and credits related to the companys acquisition activity, net income rose 39%, from 1998s $262 million to $364 million.
Boston Scientific attributed its increased income in part to the completion of its acquisition of Schneider Worldwide, a division of Pfizers Medical Technology Group, which the company agreed to purchase in 1998 for $2.1 billion in cash (SCAN 6/24/98). Schneider operates out of Bulach, Switzerland, and manufactures stents and angioplasty devices and accessories. With Schneider under its corporate umbrella, Boston Scientific has gained access to high-growth areas of interventional medicine products, including rapid-exchange catheters and nylon balloon technology.
Study Reaffirms Low Risk for csPCa with Biopsy Omission After Negative Prostate MRI
December 19th 2024In a new study involving nearly 600 biopsy-naïve men, researchers found that only 4 percent of those with negative prostate MRI had clinically significant prostate cancer after three years of active monitoring.
Study Examines Impact of Deep Learning on Fast MRI Protocols for Knee Pain
December 17th 2024Ten-minute and five-minute knee MRI exams with compressed sequences facilitated by deep learning offered nearly equivalent sensitivity and specificity as an 18-minute conventional MRI knee exam, according to research presented recently at the RSNA conference.
Can Radiomics Bolster Low-Dose CT Prognostic Assessment for High-Risk Lung Adenocarcinoma?
December 16th 2024A CT-based radiomic model offered over 10 percent higher specificity and positive predictive value for high-risk lung adenocarcinoma in comparison to a radiographic model, according to external validation testing in a recent study.
